Circulating Biomarkers 2014 Dundee

In an effort to strengthen the link between emerging knowledge and technologies and personalized healthcare decision points, this conference brings together experts in the area of circulating biomarkers.
Experts will be speaking in the areas of:
- circulating tumour cells (CTCs)
- circulating micro-RNA (miRNA)
- circulating free DNA (cfDNA)
and how biomarkers can be used for better patient healthcare decisions.

+ show speakers and program
Day 1

9.30 – 10.45: Registration, Coffee and Networking

10.45 – 11.00: Opening

11.00 – 11.35: Prof Jacqui Shaw, Translational Cancer Genetics, University of Leicester

11.35 – 12.10: Prof Sean Grimmond, Medical Genomics, Wolfson Wohl Cancer Research Centre, University of Glasgow
Testing the clinical utility of personalised cancer genomics in advanced pancreatic cancer

12.10 – 12.25: Networking Mini Workshop

12.25 – 13.30: Lunch, Exhibition and Networking

13.30 – 14.05: Technology Workshop by Silicon Biosystems
Advanced solution for CTC molecular characterization

14.05 – 14.40: Prof Caroline Dive, Cancer Research UK Manchester Institute
CTC in lung cancer, Biology, Mouse models and Biomarkers

14.40 – 15.15: Dr James Dear, Pharmacology, Therapeutics and Toxicology Unit, University of Edinburgh

15.15 – 15.45: Coffee Break, Exhibition & Networking

15.45 – 16.20: Prof Nicol Keith, Molecular Oncology, Wolfson Wohl Cancer Research Centre, University of Glasgow
Proof-of-concept biomarker integration into clinical trials

16.20 – 16.55: Prof Michael Kerin, Surgery and Head of Discipline at NUI Galway and Galway University Hospitals
microRNAs as diagnostic tools in breast cancer

16.55 – 17.30: Dr Dana Tsui, Cancer Research UK Cambridge Institute
Circulating tumour DNA for Non-invasive Cancer Management

Day 2

09.00 – 09.35: Prof Charles Coombes, Medical Oncology, Imperial College London
Breast Cancer: Progress in Monitoring Minimal Residual Disease

09.35 – 10.10: Dr Alastair Greystoke, Medical Oncology, Newcastle upon Tyne NHS Foundation Trust
Adaptive clinical trials in early drug development; potential and limitations of circulating biomarkers

10.10 – 10.45: Coffee Break, Exhibition & Networking

10.45 – 11.20: Prof Angie Cox, Academic unit of Molecular Oncology, University of Sheffield
Lung Cancer miRNA’s

11.20 – 11.55: Dr Daniel Antoine, Molecular and Clinical Pharmacology, University of Liverpool
Liver Injury miRNA biomarkers

11.55 – 12.30: Dr Dawn Coverley, Department of Biology, University of York & Cizzle Biotech
Variant CIZ1 is a circulating biomarker for early stage lung cancer

1 Oct - 2 Oct 2014

United Kingdom
meeting website